-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 G5QTWiRbpr6s+rpMY7gFZB3OG3ayjGfdff2XQ9OVLBnObpkCVHg9yWmwjNurQrc7
 z6mEH31K3uueC/uKW7RhrA==

<SEC-DOCUMENT>0000891836-07-000333.txt : 20071113
<SEC-HEADER>0000891836-07-000333.hdr.sgml : 20071112
<ACCEPTANCE-DATETIME>20071113111927
ACCESSION NUMBER:		0000891836-07-000333
CONFORMED SUBMISSION TYPE:	SC 13D/A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20071113
DATE AS OF CHANGE:		20071113

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MEDQUIST INC
		CENTRAL INDEX KEY:			0000884497
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
		IRS NUMBER:				222531298
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-42936
		FILM NUMBER:		071235669

	BUSINESS ADDRESS:	
		STREET 1:		1000 BISHOPS GATE BLVD
		STREET 2:		SUITE 300
		CITY:			MOUNT LAUREL
		STATE:			NJ
		ZIP:			08054-4632
		BUSINESS PHONE:		8568108000

	MAIL ADDRESS:	
		STREET 1:		1000 BISHOPS GATE BLVD
		STREET 2:		SUITE 300
		CITY:			MOUNT LAUREL
		STATE:			NJ
		ZIP:			08054-4632

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KONINKLIJKE PHILIPS ELECTRONICS NV
		CENTRAL INDEX KEY:			0000313216
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTRONIC & OTHER ELECTRICAL EQUIPMENT (NO COMPUTER EQUIP) [3600]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			P7
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		BREITNER CENTER
		STREET 2:		AMSTELPLEIN 2
		CITY:			AMSTERDAM
		STATE:			P7
		ZIP:			1096 BC
		BUSINESS PHONE:		31 20 59 77777

	MAIL ADDRESS:	
		STREET 1:		BREITNER CENTER
		STREET 2:		AMSTELPLEIN 2
		CITY:			AMSTERDAM
		STATE:			P7
		ZIP:			1096 BC

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHILIPS ELECTRONICS N V
		DATE OF NAME CHANGE:	19930727

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHILIPS NV
		DATE OF NAME CHANGE:	19910903
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D/A
<SEQUENCE>1
<FILENAME>sc0145.txt
<DESCRIPTION>AMENDMENT NO. 6
<TEXT>


                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                 SCHEDULE 13D/A
                    Under the Securities Exchange Act of 1934

                                (Amendment No. 6)

                                  MedQuist Inc.
- --------------------------------------------------------------------------------
                                (Name of Issuer)


                           Common Stock, No Par Value
- --------------------------------------------------------------------------------
                         (Title of Class of Securities)


                                    584949101
- --------------------------------------------------------------------------------
                                 (CUSIP Number)


                             Neil T. Anderson, Esq.
                             Sullivan & Cromwell LLP
                                125 Broad Street
                          New York, New York 10004-2498
                                 (212) 558-4000
- --------------------------------------------------------------------------------
            (Name, Address and Telephone Number of Person Authorized
                     to Receive Notices and Communications)


                                November 8, 2007
- --------------------------------------------------------------------------------
             (Date of Event which Requires Filing of this Statement)

If a filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of ss.ss. 240.13d-1(e), 240.13d-1(f) or 240.13d- 1(g), check
the following box [ ].





<PAGE>
- --------------------------------------------------------------------------------
CUSIP NO. 584949101
- --------------------------------------------------------------------------------
 1.      NAME OF REPORTING PERSON

         Koninklijke Philips Electronics N.V.

         I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

         222531298
- --------------------------------------------------------------------------------
 2.      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
                                                                (a)  [_]
                                                                (b)  [_]
- --------------------------------------------------------------------------------
 3.      SEC USE ONLY

- --------------------------------------------------------------------------------
 4.      SOURCE OF FUNDS
         OO
- --------------------------------------------------------------------------------
 5.      CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
         REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
                                                                     [_]
- --------------------------------------------------------------------------------
 6.      CITIZENSHIP OR PLACE OF ORGANIZATION

         The Netherlands
- --------------------------------------------------------------------------------
                  7.       SOLE VOTING POWER
  NUMBER OF                26,085,086
    SHARES        --------------------------------------------------------------
BENEFICIALLY      8.       SHARED VOTING POWER
  OWNED BY                 0
    EACH          --------------------------------------------------------------
 REPORTING        9.       SOLE DISPOSITIVE POWER
   PERSON                  26,085,086
    WITH          --------------------------------------------------------------
                  10.      SHARED DISPOSITIVE POWER
                           0
- --------------------------------------------------------------------------------
11.      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
         PERSON
          26,085,086
- --------------------------------------------------------------------------------
12.      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
         CERTAIN SHARES
                                                                     [_]
- --------------------------------------------------------------------------------
13.      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

         69.6%
- --------------------------------------------------------------------------------
14.      TYPE OF REPORTING PERSON
         CO

- --------------------------------------------------------------------------------

                                      -2-
<PAGE>

Item 1.  Security and Issuer.

         This Amendment No. 6 relates to the common stock, no par value (the
"Shares") of MedQuist Inc., a New Jersey corporation ("MedQuist"). This
Amendment No. 6 amends and supplements Item 6 and Item 7 of the Statement on
Schedule 13D dated June 6, 2000 (the "Schedule 13D") filed by Koninklijke
Philips Electronics N.V., a corporation incorporated under the laws of The
Netherlands ("Philips"), as previously amended and supplemented by Amendment No.
1 to the Schedule 13D, dated July 28, 2000, Amendment No. 2 to the Schedule 13D,
dated August 2, 2000, Amendment No. 3 to the Schedule 13D, dated August 24,
2000, Amendment No. 4 to the Schedule 13D, dated July 6, 2007 and Amendment No.
5 to the Schedule 13D, dated November 2, 2007. Unless otherwise defined herein,
all capitalized terms used herein shall have the meanings ascribed to them in
the Schedule 13D.

Item 6.  Contracts, Arrangements, Understandings
         or Relationships with Respect to
         Securities of the Issuer.

         On November 8, 2007, MedQuist and Philips entered into an amendment
(the "Amendment") of the Governance Agreement by and between MedQuist and
Philips dated May 22, 2000 (the "Governance Agreement"). The Supervisory
Committee of the Board of Directors of MedQuist (the "Board"), responsible for,
among other things, the general oversight, administration, amendment and
enforcement of all material agreements or arrangements between MedQuist and
Philips, approved the Amendment.

         The Amendment establishes the composition of the Board in the event the
number of directors constituting the whole Board is set at seven (its current
size). It also provides for vacancies in Board seats held by Independent
Directors (as defined in the Governance Agreement) to be filled by an
affirmative vote of the remaining directors in the event there are no
Independent Directors on the Board.

         A complete copy of the Amendment is attached to this report as
Exhibit 1 and is incorporated herein by reference.

Item 7.  Material to be Filed as Exhibits

         Exhibit         Description
         -------         -----------

            1            Amendment, dated November 8, 2007, to the Governance
                         Agreement, dated May 22, 2000, between Philips and
                         MedQuist.


                                      -3-

<PAGE>


                                   SIGNATURES

         After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.

Date:  November 13, 2007



                                    KONINKLIJKE PHILIPS ELECTRONICS N.V.

                                    By:    /s/  P.J. SIVIGNON
                                        ----------------------------------------
                                    Name:   P.J. Sivignon
                                    Title:  Executive Vice President & CFO


                                    By:    /s/  E.P. COUTINHO
                                        ----------------------------------------
                                    Name:   E.P. Coutinho
                                    Title:  General Secretary
                                            and Chief Legal Officer






                                      -4-
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit_1.txt
<DESCRIPTION>AMENDMENT TO GOVERNANCE AGMT
<TEXT>
                                                                       Exhibit 1

November 8, 2007

Koninklijke Philips Electronics N.V.
Rembrandt Tower
Amstelplein 1
1096 HA Amsterdam,
The Netherlands

     Re: Amendment to the Governance Agreement by and between Koninklijke
     Philips Electronics N.V. ("Purchaser") and MedQuist Inc. (the "Company")
     dated May 22, 2000 (the "Governance Agreement")

Ladies and Gentleman:

This letter constitutes an amendment to the Governance Agreement. The Governance
Agreement shall be amended as follows:

   o  A new Section 3.01(g) is hereby added to the Governance Agreement to read
      as follows:

         If the number of directors constituting the whole Board of Directors
         shall be fixed at seven directors and Purchaser and its Subsidiaries
         shall beneficially own, in the aggregate, at least a majority of the
         outstanding Voting Stock, the Board of Directors shall consist of four
         Purchaser Directors and three Independent Directors.

   o  A new sentence is added to the end of Section 3.4(a) to read as follows:

         Notwithstanding anything in this Agreement to the contrary, in the
         event that at any time there shall be no Independent Directors on the
         Board of Directors, whether by reason of death, resignation,
         retirement, disqualification, removal from office or other causes, such
         vacancies shall be filled by an affirmative vote of the remaining
         directors as provided in the by-laws.

Except as amended hereby, all of the terms and provisions of the Governance
Agreement shall remain in full force and effect.

Please indicate your agreement with the above amendment by signing where
indicated below and returning one copy of this letter amendment to MedQuist
Inc., 1000 Bishops Gate Blvd., Suite 300, Mt. Laurel, New Jersey 08054, USA,
Attention: General Counsel. All capitalized terms not defined herein shall have
the same meanings as given to them in the Governance Agreement. Pursuant to the
terms of the Governance Agreement, this letter amendment has been approved by
the Supervisory Committee and will be effective as of the date it is executed by
Purchaser as indicated below.

                                        Sincerely,
                                        MedQuist Inc.
                                        By: /s/ Howard S. Hoffmann
                                        -----------------------------------
                                        Howard S. Hoffmann, CEO & President
Agreed by:
Koninklijke Philips Electronics N.V.
By: /s/ Stephen H. Rusckowski
- ------------------------------------
Stephen H. Rusckowski
Member, Royal Philips Board of
Management (Medical Systems)
Date: November 8, 2007
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
